Home > Cancer and Treatments > Pancreatic Cancer

Pancreatic Cancer Clinical Trials

Clinical trials are research studies that play a key role in finding better ways to treat cancer.

The following is a list of pancreatic cancer clinical trials studying:

Operable cancer (resectable) or border-line operable

UMCC 2006.025HUM00004531:
A Multi-Institutional Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin with Radiation Therapy in Patients with Pancreatic Cancer. For more information about this study, read about it on the Engage web site or call Janet Hampton OCN, RN 734-615-8839.

Locally advanced disease (disease that has not spread)

UMCC 2006.076
Phase II Study of combined gemcitabine, 5-fluorouracil and bevacizumab in patients with stage III or IV, advanced pancreatic cancer. For more information about this study, call Janet Hampton OCN, RN 734-615-8839.

UMCC 2006.018HUM00003315:
A Phase I/II Radiation Dose-Escalation Study of Intensity-Modulated Radiotherapy (IMRT) with Concurrent Gemcitabine in Patients with Unresectable Pancreatic Cancer. For more information about this study, read about it on the Engage web site or call Janet Hampton OCN, RN 734-615-8839.

Metastatic disease (disease that has spread)

UMCC 2006.076
Phase II Study of combined gemcitabine, 5-fluorouracil and bevacizumab in patients with stage III or IV, advanced pancreatic cancer. For more information about this study, call Janet Hampton OCN, RN 734-615-8839.

UMCC 2005.135HUM00003130:
A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-Pulsed Dendritic Cells with Tumoral Radiation Therapy in Patients with Metastatic Pancreatic Cancer. For more information about this study, call Janet Hampton OCN, RN 734-615-8839.

Last update 4/2008

Adjust text size

University of Michigan Comprehensive Cancer Center
1500 East Medical Center Drive
Ann Arbor, MI 48109

This site is part of the U-M Health System. The information presented is not a tool for self diagnosis or a substitute for professional care. © 2008 U-M Comprehensive Cancer Center